## **Core Concept**
The question revolves around the management of levodopa-induced vomiting, a common side effect in patients with Parkinson's disease treated with levodopa. Levodopa is a precursor to dopamine, and its use can lead to increased dopaminergic activity, which may cause nausea and vomiting.

## **Why the Correct Answer is Right**
The correct answer, **Metoclopramide**, is a prokinetic agent and antiemetic that works by blocking dopamine receptors in the chemoreceptor trigger zone of the central nervous system. Unlike other antiemetics that may also block dopamine receptors but have different primary uses or side effect profiles, metoclopramide is effective in treating levodopa-induced vomiting without significantly interfering with the anti-parkinsonian effects of levodopa.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Although an antihistamine with antiemetic properties, it is not the drug of choice for levodopa-induced vomiting due to its sedative side effects and less potent antiemetic effects compared to metoclopramide in this context.
- **Option B:** This option might seem plausible due to its antiemetic effects, but it is not typically used as a first-line treatment for levodopa-induced vomiting.
- **Option D:** While ondansetron is a potent antiemetic, it is primarily used for chemotherapy-induced nausea and vomiting and is not the first choice for levodopa-induced vomiting.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that metoclopramide is often used to manage levodopa-induced nausea and vomiting. However, it's worth noting that long-term use of metoclopramide can lead to adverse effects such as tardive dyskinesia, which is particularly concerning in patients with Parkinson's disease.

## **Correct Answer:** . Metoclopramide